Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by TheeRookon Jan 22, 2021 2:27pm
198 Views
Post# 32361063

RE:RE:RE:An other tweet

RE:RE:RE:An other tweetBetter check that CE Mark , it looks like its just for products like a toaster

A health test needs The CE-IVD mark is in conformance with the European Union in ivitro diagnostic directive.

Advanta Dx will be one of the first saliva-based COVID-19 tests to be made available throughout Europe. Fluidigm plans to sell Advanta Dx for as little as 5 euros per test. There's a big opportunity for the company: The total European market for COVID-19 testing this year is projected to be between $5 billion and $7 billion. 



dart321 wrote: You hear that massive sucking sound getting louder by the minute. That is the sound of all the tests and vaccines being manufactured in the EU being sucked up by the Biden defence production act.


<< Previous
Bullboard Posts
Next >>